ANI Pharmaceuticals, Inc.
- ANIP
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Generic Pharmaceuticals
- Specialty Pharmaceuticals (Injectables)
- Rare Disease (Cortrophin Gel)
$72.56
Today +0.37%Quote Oct 19, 2026, 08:00 PM UTC
−4.70%over the last month
Max drawdown −11.0%From 1-month high −8.0%3 months −8.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
Where the money comes from
Q2 2026 revenue $266.0M
- Sales of rare disease pharmaceutical products$135.8M51.1%
- Total Sales of Generics and Other$100.7M37.8%
- Sales of Established Brands$11.8M4.4%
- Other / not reported$17.7M6.7%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
970
Founded
2001
Market value
$1.67B
Quote Oct 19
Floor
$72.16
0.6% below price
Resistance
$72.47
Price is above this level
Price vs analyst targets
10 analysts
Lowest target
$85.00Highest target
$119.00
$85.00Highest target
$119.00
- Price $72.56
- Average target $99.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 37% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ANIPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free